Mednax Inc (MD)
Return on total capital
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | -60,598 | -6,284 | 200,000 | 217,738 | 171,933 |
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 764,938 | 849,061 | 891,632 | 896,692 | 747,717 |
| Return on total capital | -7.92% | -0.74% | 22.43% | 24.28% | 22.99% |
December 31, 2024 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $-60,598K ÷ ($—K + $764,938K)
= -7.92%
The return on total capital for Mednax Inc has shown fluctuating trends over the years as follows:
- As of December 31, 2020, the return on total capital was strong at 22.99%, indicating that the company efficiently generated profits from the total capital employed.
- By December 31, 2021, the return improved further to 24.28%, reflecting continued effectiveness in utilizing its total capital resources.
- However, as of December 31, 2022, the return on total capital decreased slightly to 22.43%, although still at a satisfactory level.
- The performance took a significant downturn by December 31, 2023, with a negative return of -0.74%, suggesting that the company experienced challenges in generating returns relative to its total capital investment.
- The trend worsened by December 31, 2024, with a notable decline in the return to -7.92%, indicating a substantial decrease in the efficiency of capital utilization, possibly due to operational or economic difficulties.
Overall, the return on total capital for Mednax Inc exhibited both positive and negative variations over the years, with the most recent data showing a concerning decline. This trend may prompt further analysis to identify factors influencing the company's capital efficiency and profitability.
Peer comparison
Dec 31, 2024